As awareness grows that GLP-1induced weight loss can include significant muscle loss, patents have begun claiming combinations with myostatin and ActRII pathway modulators [14, 15], while scientific papers examine the mechanisms and clinical implications of body composition changes during incretin therapy [13, 23]
GLP-1 receptor agonists reduce mortality in lower-risk patients, although absolute benefits are smaller
To overcome this problem, many individuals are now exploring advanced dermatological treatments that go beyond creams and serums
With generics now on the market, Canadian prices will fall even further
In the Wegovy clinical trials, 2% of users experienced a rare skin sensitivity reaction that feels like burning or tingling (dysesthesia). Contact your health provider for advice if this happens
That depletion is what most women never get told about